Lopez-Collazo E, Hurtado-Navarro L
Front Immunol. 2025; 16:1524781.
PMID: 39967663
PMC: 11832717.
DOI: 10.3389/fimmu.2025.1524781.
Shabo I, Midtbo K, Branstrom R, Lindstrom A
PLoS One. 2025; 20(1):e0311027.
PMID: 39752516
PMC: 11698428.
DOI: 10.1371/journal.pone.0311027.
Laplane L, Maley C
Nat Rev Cancer. 2024; 24(10):718-733.
PMID: 39256635
PMC: 11627115.
DOI: 10.1038/s41568-024-00734-2.
Patel R, Parappilly M, Rahman S, Schwantes I, Sewell M, Giske N
Results Probl Cell Differ. 2023; 71:467-485.
PMID: 37996690
DOI: 10.1007/978-3-031-37936-9_21.
Sieler M, Dittmar T
Results Probl Cell Differ. 2023; 71:433-465.
PMID: 37996689
DOI: 10.1007/978-3-031-37936-9_20.
Mechanisms of Cell Fusion in Cancer.
Noubissi F, Odubanjo O, Ogle B, Tchounwou P
Results Probl Cell Differ. 2023; 71:407-432.
PMID: 37996688
PMC: 10893907.
DOI: 10.1007/978-3-031-37936-9_19.
You complete me: tumor cell-myeloid cell nuclear fusion as a facilitator of organ-specific metastasis.
Cozzo A, Coleman M, Hursting S
Front Oncol. 2023; 13:1191332.
PMID: 37427108
PMC: 10324515.
DOI: 10.3389/fonc.2023.1191332.
Intrinsic signalling factors associated with cancer cell-cell fusion.
Dittmar T, Hass R
Cell Commun Signal. 2023; 21(1):68.
PMID: 37016404
PMC: 10071245.
DOI: 10.1186/s12964-023-01085-5.
Extracellular Events Involved in Cancer Cell-Cell Fusion.
Dittmar T, Hass R
Int J Mol Sci. 2022; 23(24).
PMID: 36555709
PMC: 9784959.
DOI: 10.3390/ijms232416071.
Generation of Cancer Stem/Initiating Cells by Cell-Cell Fusion.
Dittmar T
Int J Mol Sci. 2022; 23(9).
PMID: 35562905
PMC: 9101717.
DOI: 10.3390/ijms23094514.
Tumor Hybrid Cells: Nature and Biological Significance.
Tretyakova M, Subbalakshmi A, Menyailo M, Jolly M, Denisov E
Front Cell Dev Biol. 2022; 10:814714.
PMID: 35242760
PMC: 8886020.
DOI: 10.3389/fcell.2022.814714.
Cell Fusion-Related Proteins and Signaling Pathways, and Their Roles in the Development and Progression of Cancer.
Zhang H, Ma H, Yang X, Fan L, Tian S, Niu R
Front Cell Dev Biol. 2022; 9:809668.
PMID: 35178400
PMC: 8846309.
DOI: 10.3389/fcell.2021.809668.
Cell-Cell Fusion Mediated by Viruses and HERV-Derived Fusogens in Cancer Initiation and Progression.
Dittmar T, Weiler J, Luo T, Hass R
Cancers (Basel). 2021; 13(21).
PMID: 34771528
PMC: 8582398.
DOI: 10.3390/cancers13215363.
Hybrid Formation and Fusion of Cancer Cells In Vitro and In Vivo.
Hass R, von der Ohe J, Dittmar T
Cancers (Basel). 2021; 13(17).
PMID: 34503305
PMC: 8431460.
DOI: 10.3390/cancers13174496.
Cell-Cell Fusion and the Roads to Novel Properties of Tumor Hybrid Cells.
Sieler M, Weiler J, Dittmar T
Cells. 2021; 10(6).
PMID: 34207991
PMC: 8230653.
DOI: 10.3390/cells10061465.
Acquisition of cancer stem cell capacities after spontaneous cell fusion.
Merle C, Lagarde P, Lartigue L, Chibon F
BMC Cancer. 2021; 21(1):241.
PMID: 33678155
PMC: 7938600.
DOI: 10.1186/s12885-021-07979-2.
Cell Fusion of Mesenchymal Stem/Stromal Cells and Breast Cancer Cells Leads to the Formation of Hybrid Cells Exhibiting Diverse and Individual (Stem Cell) Characteristics.
Dornen J, Myklebost O, Dittmar T
Int J Mol Sci. 2020; 21(24).
PMID: 33348862
PMC: 7765946.
DOI: 10.3390/ijms21249636.
Cell-cell fusion of mesenchymal cells with distinct differentiations triggers genomic and transcriptomic remodelling toward tumour aggressiveness.
Delespaul L, Gelabert C, Lesluyes T, Le Guellec S, Perot G, Leroy L
Sci Rep. 2020; 10(1):21634.
PMID: 33303824
PMC: 7729932.
DOI: 10.1038/s41598-020-78502-z.
Tumor stem cells fuse with monocytes to form highly invasive tumor-hybrid cells.
Aguirre L, Montalban-Hernandez K, Avendano-Ortiz J, Marin E, Lozano R, Toledano V
Oncoimmunology. 2020; 9(1):1773204.
PMID: 32923132
PMC: 7458638.
DOI: 10.1080/2162402X.2020.1773204.
Comparison of hybrid clones derived from human breast epithelial cells and three different cancer cell lines regarding in vitro cancer stem/ initiating cell properties.
Fahlbusch S, Keil S, Epplen J, Zanker K, Dittmar T
BMC Cancer. 2020; 20(1):446.
PMID: 32430004
PMC: 7236176.
DOI: 10.1186/s12885-020-06952-9.
